Hypertension in black Americans as a special population: Why so special?
- 67 Downloads
Studies have shown that appropriate treatment of hypertension will reduce cardiovascular, renal, and cerebrovascular morbidity and mortality for all patients. Because hypertension has a multifaceted nature the disorder presents with unique features in prevalence, morbidity, and mortality among ethnic groups. Blacks, Hispanics, and Native Americans have been identified as special populations at risk for unique experiences with hypertension. Among these special populations, black Americans present unique issues in etiology, pathophysiology, severity, and response to treatment. This article reviews the varied aspects of hypertension detection, treatment, and control as they relate to the special population of black Americans.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252. This is the major consensus group document produced by the National Heart, Lung, and Blood Institute, which administers the National High Blood Pressure Education Program Coordinating Committee, a coalition of major professional, public, voluntary organizations and seven federal agencies.Google Scholar
- 6.American Heart Association. Heart Disease and Stroke Statistics - 2003. Update. Dallas, TX: American Heart Association; 2003.Google Scholar
- 8.Chobanian AV, Bakris GL, Black HR, et al.: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2002, 289:2534–2573.Google Scholar
- 9.The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid - Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2997.CrossRefGoogle Scholar
- 10.Saunders E: Hypertension in the Black Population: Measures for Improving the Outlook. CVR & R February 1992:49–51.Google Scholar
- 11.Douglas JG, Bakris GL, Murray E, et al.: Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 2003, 163:525–541. This is the consensus document of the International Society on Hypertension in Blacks, a major international group that focuses on hypertension in blacks.PubMedCrossRefGoogle Scholar
- 15.Johnson W: Value of outcomes-based trials. Cardiol Rev 2002, 19:16.Google Scholar
- 17.Julius S, Nesbitt SD, Egan BM, et al., for the Trial of Preventing Hypertension (TROPHY) Study Investigators: Feasibility of treating prehypertension with an angiotensinreceptor blocker. N Engl J Med 2006, 354:1685–1697. This article is a review of the TROPHY study results.PubMedCrossRefGoogle Scholar
- 18.ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2997.CrossRefGoogle Scholar